![](https://webarchive.library.unt.edu/eot2008/20090114233033im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090114233033im_/http://www.cancer.gov/images/spacer.gif)
dideoxyadenosine A synthetic nucleoside analogue of deoxyadenosine and a prodrug of didanosine in which the 3' hydroxyl group on the ribose moiety is replaced by a hydrogen atom. Dideoxyadenosine competitively inhibits adenylyl cyclase, thereby reducing levels of cyclic adenosine monophosphate (cAMP). By inhibiting cAMP-mediated gene activation in tumor cells, this agent may retard tumor cell proliferation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/eot2008/20090114233033im_/http://www.cancer.gov/images/spacer.gif)
Abbreviation: | ![](https://webarchive.library.unt.edu/eot2008/20090114233033im_/http://www.cancer.gov/images/spacer.gif) | ddA | | ![](https://webarchive.library.unt.edu/eot2008/20090114233033im_/http://www.cancer.gov/images/spacer.gif) | Chemical structure names: | ![](https://webarchive.library.unt.edu/eot2008/20090114233033im_/http://www.cancer.gov/images/spacer.gif) | - 2',3'-Dideoxyadenosine
- 6-Amino-9-(2''3'-dideoxy-beta-D-glycero-pentofuranosyl)purine
| | ![](https://webarchive.library.unt.edu/eot2008/20090114233033im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090114233033im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090114233033im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090114233033im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20090114233033im_/http://www.cancer.gov/images/spacer.gif) |